In vivo effect of surfactant on inflammatory cytokines during endotoxin-induced lung injury in rodents

Journal of Immunotoxicology

Volumn 8, Issue 4, 2011, Pages 274-283

  Mittal, Neha ^a   Sanyal, Sankar Nath ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

ARDS; Cytokines; Immunofluorescence; LPS; Surfactant

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL SURFACTANT; SURFACTANT; SYNTHETIC SURFACTANT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOFLUORESCENCE; IN VIVO STUDY; INFLAMMATORY CELL; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKINS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICROSCOPY, FLUORESCENCE; PULMONARY SURFACTANTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS; RODENTIA; SUS;

EID: 80455174092     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2011.591294     Document Type: Article

References (44)

1. Arias-Diaz, J., Garcia-Verdugo, I., Casals, C., Sanchez-Rico, N., Vara, E. and Balibrea, J. L. 2000. Effect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages. Shock. 14:300-306.
2. Baggiolini, M., Dewald, B. and Moser, B. 1997. Human chemokines: An update. Annu Rev Immunol. 15:675-705.
3. Balibrea, J. L. and Arias-Díaz, J. 2003. Acute respiratory distress syndrome in the septic surgical patient. World J Surg. 27:1275-1284.
4. Bastarache, J. A. and Blackwell, T. S. 2009. Development of animal models for the acute respiratory distress syndrome. Dis Model Mech. 2:218-223.
5. Becker, S. and Soukup, J. M. 1999. Exposure to urban air particulates alters the macrophage-mediated inflammatory response to respiratory viral infection. J Toxicol Environ Health Part A. 57:445-457.
6. Beck-Schimmer, B., Schwendener, R., Pasch, T., Reyes, L., Booy, C. and Schimmer, R. C. 2005. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res. 6:61.
7. Borron, P., McIntosh, J. C., Korfhagen, T. R., Whitsett, J. A., Taylor, J. and Wright, J. R. 2000. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol. 278:L840-L847.
8. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254.
9. Chabot, S., Salez, L., McCormack, F. X., Touqui, L. and Chignard, M. 2003. Surfactant protein A inhibits lipopolysaccharideinduced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am J Respir Cell Mol Biol. 28:347-353.
10. Chen, H., Bai, C. and Wang, X. 2010. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 4:773-783.
11. Donnelly, S. C., Haslett, C., Reid, P. T., Grant, I. S., Wallace, W. A., Metz, C. N., Bruce, L. J. and Bucala, R. 1997. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 3:320-323.
12. Galani, V., Tatsaki, E., Bai, M., Kitsoulis, P., Lekka, M., Nakos, G. and Kanavaros, P. 2010. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): An up-to-date cellspecific review. Pathol Res Pract. 206:145-150.
13. Germann, P. G. and Häfner, D. 1998. A rat model of acute respiratory distress syndrome (ARDS): Part 1. Time dependency of histological and pathological changes. J Pharmacol Toxicol Methods. 40:101-107.
14. Gregory, T. J., Longmore, W. J., Moxley, M. A., Whitsett, J. A., Reed, C. R., Fowler, A. A., 3rd, Hudson, L. D., Maunder, R. J., Crim, C., and Hyers, T. M. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 88:1976-1981.
15. Hocke, A. C., Ermert, M., Althoff, A., Brell, B., N'Guessan, P. D., Suttorp, N. and Ermert, L. 2006. Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs. Comparison of the constitutive expression between rats and humans. Cytokine. 33:199-211.
16. Jacobs, R. F., Tabor, D. R., Burks, A. W. and Campbell, G. D. 1989. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis. 140:1686-1692.
17. Janssen, W. J., Barthel, L., Muldrow, A., Oberley-Deegan, R. E., Kearns, M. T., Jakubzick, C. and Henson, P. M. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med. (In press).
18. Kinoshita, M., Mochizuki, H. and Ono, S. 1999. Pulmonary neutrophil accumulation following human endotoxemia. Chest. 116:1709-1715.
19. Kesecioglu, J., Schultz, M. J., Lundberg, D., Lauven, P. M., and Lachmann, B. 2001. Treatment of acute lung injury (ALI/ARDS) with surfactant. Am J Respir Crit Care Med. 163:A819.
20. Li, S. L., Wu, Z. H., Zhang, S. Q., Qin, C. P., Li, T., Chen, Z. T., Jin, J. S., MA, S. F. and Li, J. 2011. The changes in secretory function of pulmonary intravascular macrophages after challenge of lipopoly saccharide. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 23:176-178.
21. Lin, W. C., Lin, C. F., Chen, C. L., Chen, C. W. and Lin, Y. S. 2010. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med (Maywood.) 235:57-65.
22. Ma, X., Xu, D., Ai, Y., Ming, G. and Zhao, S. 2010. Fas inhibition attenuates lipopolysaccharide-induced apoptosis and cytokine release of rat Type II alveolar epithelial cells. Mol Biol Rep. 37:3051-3056.
23. Martin, T. R. 1997. Cytokines and the acute respiratory distress syndrome (ARDS): A question of balance. Nat Med. 3:272-273.
24. Martin, T. R., Donnelly, S. C., Steinberg, K. P., Ruzinski, J. T., Metz, C. N., Goodman, R. B., Hudson, L. D., and Bucala, R. 1998. Macrophage inhibitory factor (MIF) in the lungs of patients with acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med. 157:A459.
25. Matute-Bello, G., Frevert, C. W. and Martin, T. R. 2008. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 295:L379-L399.
26. McCormack, F. 1997. The structure and function of surfactant protein-A. Chest. 111:114S-119S.
27. McIntosh, J. C., Mervin-Blake, S., Conner, E. and Wright, J. R. 1996. Surfactant protein A protects growing cells and reduces TNF-a activity from LPS-stimulated macrophages. Am J Physiol. 271:L310-L319.
28. Mitchell, R. S. 1999. Lung cytokines and ARDS. Chest. 116:2S-8S. Mittal, N. and Sanyal, S. N. 2009. Exogenous surfactant suppresses inflammation in experimental endotoxin-induced lung injury. J Environ Pathol Toxicol Oncol. 28:341-349.
29. Mittal, N. and Sanyal, S. N. 2009. Exogenous surfactant suppresses inflammation in experimental endotoxin-induced lung injury. J Environ Pathol Toxicol Oncol. 28:341-349.
30. Mittal, N., and Sanyal, S. N. 2010a. Cyclooxygenase inhibition enhances the effects of surfactant therapy in endotoxin induced rat model of ARDS. Inflammation; 34:92-98.
31. Mittal, N., and Sanyal, S. N. 2010b. Immunomodulatory properties of exogenous surfactant in adult rat alveolar macrophages. Immunopharm Immunotoxicol. 32:153-159.
32. Mittal, N., and Sanyal, S. N. 2010c. Intratracheal instillation of surfactant inhibits LPS-induced acute respiratory distress syndrome in rats. Am J Biomed Sci. 2:190-201.
33. Mittal, N., and Sanyal, S. N. 2011. Exogenous surfactant prevents the mitochondrial depolarization and changes in Ca2+ homeostasis due to oxidative stress leads to apoptosis in experimental lung injury. Inst Integr Omics Biotech. (In press).
34. Mirzapoiazova, T., Kolosova, I. A., Moreno, L., Sammani, S., Garcia, J. G. and Verin, A. D. 2007. Suppression of endotoxin-induced inflammation by taxol. Eur Respir J. 30:429-435.
35. Pittet, J. F., Mackersie, R. C., Martin, T. R. and Matthay, M. A. 1997. Biological markers of acute lung injury: Prognostic and pathogenetic significance. Am J Respir Crit Care Med. 155:1187-1205.
36. Pugin, J., Ricou, B., Steinberg, K. P., Suter, P. M. and Martin, T. R. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 153:1850-1856.
37. Temmesfeld-Wollbrück, B., Walmrath, D., Grimminger, F. and Seeger, W. 1995. Prevention and therapy of the adult respiratory distress syndrome. Lung. 173:139-164.
38. Thomassen, M. J., Antal, J. M., Barna, B. P., Divis, L. T., Meeker, D. P. and Wiedemann, H. P. 1996. Surfactant down-regulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts. Am J Physiol. 270:L159-L163.
39. Tomashefski, J. F., Jr. 2000. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 21:435-466.
40. Tutor, J. D., Mason, C. M., Dobard, E., Beckerman, R. C., Summer, W. R. and Nelson, S. 1994. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med. 149:1107-1111.
41. Warren, H. S., Fitting, C., Hoff, E., Adib-Conquy, M., Beasley-Topliffe, L., Tesini, B., Liang, X., Valentine, C., Hellman, J., Hayden, D. and Cavaillon, J. M. 2010. Resilience to bacterial infection: Difference between species could be due to proteins in serum. J Infect Dis. 201:223-232.
42. Yamada, M., Kubo, H., Kobayashi, S., Ishizawa, K., He, M., Suzuki, T., Fujino, N., Kunishima, H., Hatta, M., Nishimaki, K., Aoyagi, T., Tokuda, K., Kitagawa, M., Yano, H., Tamamura, H., Fujii, N. and Kaku, M. 2011. The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury. Cell Mol Immunol. (In press).
43. Yeh, C. C., Kao, S. J., Lin, C. C., Wang, S. D., Liu, C. J. and Kao, S. T. 2007. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80:1821-1831.
44. Zhang, Q., Li, Q., Mao, B. L., Qian, G. S., Xu, J. C. and Chen, Z. T. 2004. Studies on the expression of mRNA of anti- and pro-inflammatory cytokines in acute lung injury induced by lipopolysaccharide in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 16:585-588.